The International AIDS Society (IAS) convened and facilitated a meeting between Act Up-Paris and Abbott in Sydney, Australia.
Abbott CEO Jean-Yves Pav?e participated in a meeting meant to resolve the crisis in which the company has dug itself in Thailand. Yet, during the meeting, Abbott refused to lift the deadly blockade of its lifesaving HIV medication Aluvia which the company is currently exerting against Thai people with AIDS.
This meeting was meant to offer Abbott an opportunity to get out of the crisis in which it has been embroiled since its February_14 announcement of a blockade of its HIV medicine Aluvia against all Thai AIDS patients.
At the meeting Act Up-Paris and Abbott put forward their points of view regarding important issues related to the HIV/AIDS pandemic.
The two organizations agreed that their most important priority is to promote access to HIV prevention, treatment and care globally. They also agreed that access to information is important through all available communications channels (including via websites and other media).
Abbott agreed to drop its lawsuit pending against Act Up-Paris.
?I?m living with HIV, and a few years ago an HIV drug by Abbott saved my life? recalls Act Up-Paris president Hugues Fischer. ?From my point of view, for Abbott to be deliberately preventing the Thais from procuring a lifesaving HIV medicine is tantamount to murder. Abbott must drop its blockade now ? to merely drop its lawsuit against Act Up-Paris is almost besides the point?, insists Hugues, referring to the lawsuit filed by Abbott on May_23 against French HIV+ Act Up-Paris group, in reprisals for the international internet demonstration which Act Up-Paris convened on the Abbott website on April_26.
?By dropping its lawsuit against people with HIV in France, Abbott Laboratories are only demonstrating that right is on the side of people with AIDS, and that Abbott?s blockade against us in Thailand is morally untenable?, comments Wirat Purahong, president of the Thai Network of People living with HIV. ?Access to Aluvia for Thai AIDS patients is a thousand times more important than access to Abbott?s corporate website. Abbott must drop its blackmail that Thai AIDS patients will only get Aluvia once the Thai government has granted Abbott a monopoly?, he adds.
The international AIDS activist community will keep up the fight to ensure universal access to HIV medicines in spite of drug company greed. Act Up-Paris and TNP+ therefore predict further netstrikes by the international AIDS activist community on the Abbott website, until the company respond to people with AIDS? call to reason that Abbott drop its current deadly Aluvia blockade against Thai positive people.
The two organizations committed to have future discussions on issues of importance to each of them.
The meeting happened on the opening day of the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention in Sydney, Australia.